Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese <it>db/db</it> mice

<p>Abstract</p> <p>Background</p> <p>Telmisartan is a well-established angiotensin II type 1 receptor blocker that improves insulin sensitivity in animal models of obesity and insulin resistance, as well as in humans. Telmisartan has been reported to function as a parti...

Full description

Bibliographic Details

Published in:	Cardiovascular Diabetology
Main Authors:	Shiota Asuka, Shimabukuro Michio, Fukuda Daiju, Soeki Takeshi, Sato Hiromi, Uematsu Etsuko, Hirata Yoichiro, Kurobe Hirotsugu, Maeda Norikazu, Sakaue Hiroshi, Masuzaki Hiroaki, Shimomura Iichiro, Sata Masataka
Format:	Article
Language:	English
Published:	BMC 2012-11-01
Subjects:	Adiponectin AMP-activated protein kinase Obesity Peroxisome proliferator-activated receptor-γ SIRT1
Online Access:	http://www.cardiab.com/content/11/1/139